What is POSC's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.05B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for POSC?

P/E (TTM) is n/a and 52-week range is $1.27 to $2.74 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s POSC figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for POSC?

The company profile lists revenue (TTM) near $683K, net income (TTM) near $-1.28B, EPS (TTM) near $-0.41 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Positron Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Niagara Falls, Illinois, US, 32.9M shares outstanding, ISIN US7373976049 when available from company profile and filing metadata.

Positron Corp

$POSC

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$1.67

-4.42%

Positron Corp

$POSC

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$1.67

-4.42%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. The firm specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.

Employees

10

Website

www.positron.com/

IPO

1994-02-10

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

OTC MARKETS

ISIN

US7373976049

Headquarters

Niagara Falls, Illinois, US

Shares outstanding

32.9M

NAICS sector

Manufacturing

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. The firm specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.

Employees

10

Website

www.positron.com/

IPO

1994-02-10

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)